OrbiMed Raises $3 Billion Through Global and Asian Private Equity Funds

OrbiMed, a leading healthcare investment firm, announced the successful fundraising of $3 billion for two new private equity funds: OrbiMed Private Investments X and OrbiMed Asia Partners VI. The OrbiMed Private Investments X raised over $1.9 billion to invest in life science venture opportunities in the United States and Europe. On the other hand, the OrbiMed Asia Partners VI raised over $1 billion to invest in healthcare growth equity and venture opportunities across Asia. Both funds aim to establish leading healthcare companies focused on biopharmaceuticals, medical devices, diagnostics, and technology-driven healthcare services. OrbiMed’s Managing Partner, Carl Gordon, expressed excitement about…